A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naive Subjects With Type 2 Diabetes (BEGIN ONCE).

Trial Profile

A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naive Subjects With Type 2 Diabetes (BEGIN ONCE).

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Apr 2017

At a glance

  • Drugs Insulin degludec (Primary) ; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Acronyms BEGIN; BEGIN-ONCE
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Apr 2016 Primary endpoint has been met. (Change from baseline in HbA1c (%)), as per an article published in the Drugs in R and D.
    • 20 Apr 2016 Results published in the Drugs in R and D
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top